Elevate Patient Outcomes & Quality Of Life Through Collaborative Stakeholder & Advocacy Partnerships & Truly Centre The Patient Voice To

Drive New Innovation & Strengthen Impact With Advanced, Practical, Progressive & Value-Adding Strategies For Patient Centricity, Engagement & Collaboration

A One-Day, Industry-Led Conference & Networking Exhibition, One America Square, Central London, 25th June 2025

08.15 Registration & Informal Networking

09.00 GIC Welcome & Morning Co-Chairs’ Opening Remarks

Dr Anthony Cunliffe, Lead Medical Adviser, Macmillan Cancer Support

Gunnar Philipp, Head of Medical Affairs Europe Major Markets & Canada, CSL Behring

PATIENTS & DECISION-MAKING

09.10 Proactive & Practical Patient Empowerment Strategies Which Enable Patients To Actively Drive Their Healthcare Journeys & Make Informed Decisions

  • Patients who actively participate in decision making have better health outcomes and satisfaction, so how can we empower patients to take a more active role in their healthcare decisions, especially in complex or life-changing situations?
  • How can we help HCPs better support patients in understanding their treatment options and explore the shift towards shared decision-making and what it means for both patients and clinicians?
  • How do we create an environment where patients feel capable and confident in making decisions which align with their needs, values and goals?

Debra Montague, Founder & Chairwoman, ALK Positive Lung Cancer UK

DOUBLE PERSPECTIVE

PATIENT ADVOCACY COMMUNICATION & COLLABORATION

09.30 Build Long-Lasting Trust & Enhance Relationships Between Pharma, Healthcare Providers, Patients & Advocates For Mutually-Beneficial Partnerships That Drive Engagement & Improve Outcomes

  • Effective communication between pharma, healthcare providers, and patient advocates is essential for improving patient care, but how can it be achieved?
  • Explore innovative ways pharma companies can collaborate with patient groups to build trust and ensure accurate information flow
  • Poor communication can lead to confusion, mistrust, and missed opportunities to improve patient outcomes, so how can pharma better support patient advocacy groups and help them amplify their voices in healthcare discussions?

09.30 Perspective 1

Phillip Ho, Global Vaccines Public Affairs, Sanofi Pasteur

Vinny Smith, Chief Executive, Meningitis Research Foundation

09.50 Perspective 2

Mary Lynne van Poelgeest-Pomfret, President, WFIPP

View The Full Programme

Don't Miss Out!

Book Before Thursday & Save £170!